High-Performance Capillary Electrophoresis-Pure Creatine Monohydrate Reduces Blood Lipids in Men and Women
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
1. A randomized, double-blind, placebo-controlled trial utilizing creatine as a potential lipid-lowering agent was conducted to determine plasma lipid, lipoprotein, glucose, urea nitrogen and creatinine profiles in men and women ranging in age from 32 to 70 years. 2. Thirty-four subjects (18 men and 16 women) with total cholesterol concentrations exceeding 200 mg/dl received either a creatine supplement (5 g of creatine plus 1 g of glucose) or a glucose placebo (6 g of glucose) for 56 days. Creatine and placebo were taken orally four times a day for 5 days and then twice a day for 51 days. Plasma analyses were measured at baseline, 4 and 8 weeks of treatment, and at 4 weeks after cessation of treatment (week 12). 3. Significant reductions in plasma total cholesterol, triacylglycerols and very-low-density lipoprotein-C occurred within the creatine monohydrate group. Minor reductions in plasma total cholesterol from baseline (233 +/- 9 mg/dl) of 6% and 5% occurred at weeks 4 and 8, respectively, before returning to baseline at week 12. Baseline triacylglycerols (194 +/- 21 mg/dl) and very-low-density lipoprotein-C (39 +/- 4 mg/dl) were reduced by 23% and 22% at weeks 4 and 8, respectively, and remained attenuated by 26% at week 12. These results remained consistent when data were separated and analysed by gender. Finally, a small, but statistically significant increase in urea nitrogen was observed in women between baseline (11.8 +/- 0.7 mg/dl) and week 8 (13.8 +/- 0.7 mg/dl, P < 0.05). No significant differences were noted for low-density lipoprotein-C, high-density lipoprotein-C, total cholesterol/high-density lipoprotein ratio, glucose, creatinine, body mass, body mass index or physical activity within or between the experimental and placebo groups. However, a trend towards reduced blood glucose levels was present in males given creatine monohydrate (P = 0.051). 4. These preliminary data suggest that creatine monohydrate may modulate lipid metabolism in certain individuals. These observations may demonstrate practical efficacy to the hyperlipidaemic patient as well as providing possible new mechanistic insights into the cellular regulation of blood lipid concentrations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this regard, creatine supplementation has been reported to help lower cholesterol and triglyceride levels [67, 196];”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [196]
In the citing paper
“In this regard, creatine supplementation has been reported to help lower cholesterol, triglycerides and/or manage blood lipid levels [77,132,133];”
From Creatine in health and disease (2021) · cites this paper as [132]
In the citing paper
“while a few human studies have reported improvements in lipid profiles with CrM [160,161], the majority have found no significant effects most have found no significant effect of CrM on the lipid profile [162–164].”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [160]
In the citing paper
“Earnest et al. [160] reported that CrM (20 grams/day for the first 5 days, followed by 10 grams/day for the remaining 51 days) reduced plasma total cholesterol, triacylglycerols, and very-low-density lipoprotein-C [160].”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [160]
Citations
Cites
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Creatine: Biosynthesis, Regulation, and Function
Walker, J. B. (1979) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470122952.ch4 · Cited by 496
EARNEST, C. P., SNELL, P. G., RODRIGUEZ, R., ALMADA, A. L., & MITCHELL, T. L. (1995) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1995.tb09854.x · Cited by 300
Self-citationRelationship between lipoprotein levels and in vivo insulin action in normal young white men
Garg, A., Helderman, J. H., Koffler, M., Ayuso, R. M. A., Rosenstock, J., & Raskin, P. (1988) · Metabolism · doi:10.1016/0026-0495(88)90157-6 · Cited by 142
Sane, T., Knudsen, P., Vuorinen-Markkola, H., Yki‐Järvinen, H., & Taskinen, M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90115-9 · Cited by 39
Guanidine Derivatives in Medicine
Steinmetz, P. R., Balko, C., & Davidoff, F. F. (1973) · New England Journal of Medicine · doi:10.1056/nejm197307192890308 · Cited by 38
Crouse, J. R., & Grundy, S. (1981) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(81)90160-8 · Cited by 19
Medical management of hyperlipidemic states.
Mj, M., & Jp, K. (1994) · PubMed · Cited by 18
Uses and Abuses of Anabolic Steroids by Athletes
Redda, K., Walker, C. A., & Barnett, G. (1989) · CRC Press eBooks · doi:10.1201/9781439805220-23 · Cited by 5
Cited by
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“In this regard, creatine supplementation has been reported to help lower cholesterol and triglyceride levels [67, 196]; reduce fat accumulation in the liver [197]; reduce homocysteine levels [198]; serve as an antioxidant [199–202]; enhance glycemic control [132, 203–205]; slow tumor growth in some types of cancers [3…”
BackgroundSelf-citationEffects of creatine supplementation on body composition, strength, and sprint performance
KREIDER, R. B., FERREIRA, M., WILSON, M., GRINDSTAFF, P., PLISK, S., REINARDY, J., CANTLER, E., & ALMADA, A. L. (1998) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199801000-00011 · Cited by 430
Self-citationPhysiological and Health Effects of Oral Creatine Supplementation
(2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200003000-00024 · Cited by 413
International Society of Sports Nutrition position stand: creatine supplementation and exercise
Buford, T. W., Kreider, R. B., Stout, J. R., Greenwood, M., Campbell, B., Spano, M., Ziegenfuss, T., Lopez, H., Landis, J., & Antonio, J. (2007) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-4-6 · Cited by 341
Metadata
- Authors
- Earnest, C. P., Almada, A. L., & Mitchell, T. L.
- Affiliations
- Texas Woman's University (US)
- Experimental and Applied Sciences, Inc., Golden, Colorado, U.S.A.
- Cooper Clinic (US)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 1996-07-01
- Volume
- 91
- Issue
- 1
- Pages
- 113-118
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W26452770
- Cited by
- 88
- References
- 10
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Natural Products and Biological Research
- Keywords
- creatine monohydrate, lipid-lowering drugs, hyperlipidemia, plasma total cholesterol, triglycerides, VLDL cholesterol, blood glucose, urea nitrogen, sex differences, dietary supplementation, lipid metabolism
- MeSH terms
- Adult, Aged, Anticholesteremic Agents, Cholesterol, Creatine, Double-Blind Method, Female, Humans, Hypercholesterolemia, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Triglycerides, Cholesterol, VLDL, Electrophoresis, Capillary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.